Aarti Drugs Statistics
Total Valuation
Aarti Drugs has a market cap or net worth of INR 48.63 billion. The enterprise value is 54.07 billion.
Market Cap | 48.63B |
Enterprise Value | 54.07B |
Important Dates
The next estimated earnings date is Friday, October 18, 2024.
Earnings Date | Oct 18, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Aarti Drugs has 91.94 million shares outstanding. The number of shares has decreased by -0.89% in one year.
Shares Outstanding | 91.94M |
Shares Change (YoY) | -0.89% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 47.22% |
Owned by Institutions (%) | 8.26% |
Float | 35.06M |
Valuation Ratios
The trailing PE ratio is 31.11 and the forward PE ratio is 20.83.
PE Ratio | 31.11 |
Forward PE | 20.83 |
PS Ratio | 2.00 |
PB Ratio | 3.80 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 34.48 |
EV / Sales | 2.23 |
EV / EBITDA | 17.90 |
EV / EBIT | 21.66 |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 44.02 |
Debt / EBITDA | 1.87 |
Debt / FCF | n/a |
Interest Coverage | 7.41 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Capital (ROIC) | 8.55% |
Revenue Per Employee | 22.77M |
Profits Per Employee | 1.47M |
Employee Count | 1,064 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -11.67% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -11.67% |
50-Day Moving Average | 536.57 |
200-Day Moving Average | 507.32 |
Relative Strength Index (RSI) | 45.10 |
Average Volume (20 Days) | 57,401 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Aarti Drugs had revenue of INR 24.23 billion and earned 1.57 billion in profits. Earnings per share was 17.01.
Revenue | 24.23B |
Gross Profit | 8.32B |
Operating Income | 2.50B |
Pretax Income | 2.16B |
Net Income | 1.57B |
EBITDA | 3.02B |
EBIT | 2.50B |
Earnings Per Share (EPS) | 17.01 |
Balance Sheet
The company has 207.70 million in cash and 5.64 billion in debt, giving a net cash position of -5.44 billion or -59.12 per share.
Cash & Cash Equivalents | 207.70M |
Total Debt | 5.64B |
Net Cash | -5.44B |
Net Cash Per Share | -59.12 |
Equity (Book Value) | 12.82B |
Book Value Per Share | 139.39 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 34.32%, with operating and profit margins of 10.30% and 6.47%.
Gross Margin | 34.32% |
Operating Margin | 10.30% |
Pretax Margin | 8.91% |
Profit Margin | 6.47% |
EBITDA Margin | 12.47% |
EBIT Margin | 10.30% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 0.19%.
Dividend Per Share | 1.00 |
Dividend Yield | 0.19% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 0.89% |
Shareholder Yield | 1.08% |
Earnings Yield | 3.21% |
FCF Yield | n/a |
Stock Splits
The last stock split was on September 30, 2020. It was a forward split with a ratio of 4.
Last Split Date | Sep 30, 2020 |
Split Type | Forward |
Split Ratio | 4 |